Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
7.20 0.11(1.48%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 45,561   558   25,300  
Cost of Revenue9,612   -   -  
Gross Profit 35,949   558   25,300  
Operating Expenses
Research Development162,900  144,709  77,743  
Selling General and Administrative146,615  60,909  24,380  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (273,566) (205,060) (76,823)
Income from Continuing Operations
Total Other Income/Expenses Net -  (15,613)(46,548)
Earnings Before Interest And Taxes(273,566)(220,673)(123,371)
Interest Expense153  199  232  
Income Before Tax(273,719)(220,872)(123,603)
Income Tax Expense439   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(274,158)(220,872)(123,603)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (274,158) (220,872) (123,603)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (274,158) (220,872) (123,603)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.